Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6584)
All Articles published online
|
Publishing Process of This Article
|
Oct 10, 2017 (publication date) through May 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Syed YA, Patel-Yadav AK, Rivers C, Singh AK. Stereotactic radiotherapy for prostate cancer: A review and future directions. World J Clin Oncol 2017; 8(5): 389-397 [PMID: 29067275 DOI: 10.5306/wjco.v8.i5.389] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v8/i5/389.htm |
| Number | Citing Articles |
| 1 |
E.S. Sukhikh, L.G. Sukhikh, A.V. Taletsky, A.V. Vertinsky, P.V. Izhevsky, I.N. Sheino. Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer. Physica Medica 2019; 62: 41 doi: 10.1016/j.ejmp.2019.04.017
|
| 2 |
Lily Chen, Bhavani S. Gannavarapu, Neil B. Desai, Michael R. Folkert, Michael Dohopolski, Ang Gao, Chul Ahn, Jeffrey Cadeddu, Aditya Bagrodia, Solomon Woldu, Ganesh V. Raj, Claus Roehrborn, Yair Lotan, Robert D. Timmerman, Aurelie Garant, Raquibul Hannan. Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.779182
|
| 3 |
Е. Сухих, E. Sukhikh, Л. Сухих, L. Sukhikh, Е. Маликов, E. Malikov, П. Ижевский, P. Izhevsky, И. Шейно, I. Sheino, А. Вертинский, A. Vertinsky, А. Баулин, A. Baulin. Uncertainty of Measurement Absorbed Dose by GAFCHROMIC EBT3 Dosimeter for Clinical Electron and Photon Beams of Medical Accelerators. Medical Radiology and radiation safety 2019; : 56 doi: 10.12737/article_5d1b46c9133942.84705406
|
| 4 |
Dorota Maria Borowicz, Agnieszka Skrobała, Marta Kruszyna-Mochalska, Julian Malicki. Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?. Radiology and Oncology 2022; 56(2): 259 doi: 10.2478/raon-2022-0010
|
| 5 |
I. Barillot, D. Antoni, J. Bellec, J. Biau, P. Giraud, C. Jenny, T. Lacornerie, A. Lisbona, V. Marchesi, F. Mornex, S. Supiot, S. Thureau, G. Noel. Bases référentielles de la radiothérapie en conditions stéréotaxiques pour les tumeurs ou métastases bronchopulmonaires, hépatiques, prostatiques, des voies aérodigestives supérieures, cérébrales et osseuses. Cancer/Radiothérapie 2018; 22(6-7): 660 doi: 10.1016/j.canrad.2018.08.001
|
| 6 |
E. S. Sukhikh, L. G. Sukhikh, A. V. Taletsky, Zh. A. Startseva, V. V. Verkhoturova, V. V. Rozanov, E. A. Selikhova. Feasibility of simultaneous integrated boost for high-dose treatment of high-risk prostate cancer. Siberian journal of oncology 2023; 22(3): 57 doi: 10.21294/1814-4861-2023-22-3-57-65
|
| 7 |
Kum Bae Kim, Sang Hyoun Choi. Postal Dosimetry Audits for the Domestic Medical Linear Accelerator. Progress in Medical Physics 2020; 31(2): 20 doi: 10.14316/pmp.2020.31.2.20
|
| 8 |
Dimitrij Dimiskovski, Trent Aland. Dosimetry implications of VMAT delivery angles and intra-fraction motion for SBRT prostate treatments. Medical Dosimetry 2023; 48(4): 249 doi: 10.1016/j.meddos.2023.05.004
|
| 9 |
Susan M. Hiniker, Quaovi Sodji, Andrew Quon, Paulina M. Gutkin, Natasha Arksey, Edward E. Graves, Frederick T. Chin, Peter G. Maxim, Maximilian Diehn, Billy W. Loo. FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00467
|
| 10 |
Mark E. Hwang, Mark Mayeda, Maria Liz, Brenda Goode-Marshall, Lissette Gonzalez, Carl D. Elliston, Catherine S. Spina, Oscar A. Padilla, Sven Wenske, Israel Deutsch. Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes. Radiation Oncology 2019; 14(1) doi: 10.1186/s13014-019-1346-5
|
| 11 |
Archis Ghate. Imputing radiobiological parameters of the linear-quadratic dose-response model from a radiotherapy fractionation plan. Physics in Medicine & Biology 2020; 65(22): 225009 doi: 10.1088/1361-6560/abb935
|
| 12 |
Ariane Lapierre, Christophe Hennequin, Amandine Beneux, Sarah Belhomme, Nicolas Benziane Ouaritini, Marie-Claude Biston, Gilles Crehange, Renaud de Crevoisier, Jean-luc Dumas, Maher Fawzi, Albert Lisbona, David Pasquier, Sandra Pelissier, Pierre Graff-Cailleaud, Pascal Pommier, Paul Sargos, Jean-Marc Simon, Stéphane Supiot, Florence Tantot, Olivier Chapet. Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology group. Critical Reviews in Oncology/Hematology 2022; 173: 103661 doi: 10.1016/j.critrevonc.2022.103661
|
| 13 |
Archis Ghate. Tutorials in Operations Research: Emerging Optimization Methods and Modeling Techniques with Applications. 2021; : 1 doi: 10.1287/educ.2021.0227
|
| 14 |
Emil Fredén, David Tilly, Anders Ahnesjö. Adaptive dose painting for prostate cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.973067
|
| 15 |
Michele Ghidini, Angelica Petrillo, Massimiliano Salati, Shelize Khakoo, Antonio Varricchio, Gianluca Tomasello, Francesco Grossi, Fausto Petrelli. Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?. Cancers 2019; 11(8): 1095 doi: 10.3390/cancers11081095
|
| 16 |
Daniela Schmitt, Oliver Blanck, Tobias Gauer, Michael K. Fix, Thomas B. Brunner, Jens Fleckenstein, Britta Loutfi-Krauss, Peter Manser, Rene Werner, Maria-Lisa Wilhelm, Wolfgang W. Baus, Christos Moustakis. Technological quality requirements for stereotactic radiotherapy. Strahlentherapie und Onkologie 2020; 196(5): 421 doi: 10.1007/s00066-020-01583-2
|
| 17 |
Emily A. Hewson, Doan Trang Nguyen, Ricky O’Brien, Jung‐Ha Kim, Tim Montanaro, Trevor Moodie, Peter B. Greer, Nicholas Hardcastle, Thomas Eade, Andrew Kneebone, George Hruby, Amy J. Hayden, Sandra Turner, Shankar Siva, Keen‐Hun Tai, Perry Hunter, Joshua Sams, Per Rugaard Poulsen, Jeremy T. Booth, Jarad Martin, Paul J. Keall. The accuracy and precision of the KIM motion monitoring system used in the multi‐institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial. Medical Physics 2019; 46(11): 4725 doi: 10.1002/mp.13784
|
| 18 |
Giulia Marvaso, Giulia Riva, Delia Ciardo, Sara Gandini, Cristiana Fodor, Dario Zerini, Sarah Pia Colangione, Giorgia Timon, Stefania Comi, Raffaella Cambria, Federica Cattani, Ottavio De Cobelli, Roberto Orecchia, Barbara A. Jereczek-Fossa. “Give me five” ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach. Medical Oncology 2018; 35(6) doi: 10.1007/s12032-018-1155-y
|
| 19 |
David Y. Mak, Danny Vesprini, Melanie Davidson. Minimizing the Risk of Acute Skin Toxicity Due to Hip Prosthesis Avoidance in Prostate Radiation Therapy. Practical Radiation Oncology 2023; 13(1): 66 doi: 10.1016/j.prro.2022.07.002
|
| 20 |
Kei Ito, Satoshi Kito, Yujiro Nakajima, Takuya Shimizuguchi, Hiroaki Ogawa, Keiji Nihei, Hiroshi Tanaka, Nao Kino, Toshiharu Yasugi, Katsuyuki Karasawa. Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study. Japanese Journal of Clinical Oncology 2019; 49(9): 856 doi: 10.1093/jjco/hyz074
|